In Research We Trust?
May 17, 1999
Web posted at: 12:50 p.m. EDT (1650 GMT)
by Jeffrey P. Kahn, Ph.D., M.P.H.
Director, Center
for
Bioethics
University of Minnesota
The research scandal of the week is that Duke University Medical Center had
its license to carry out clinical research revoked and then reinstated by
the federal government. This comes on the heels of disclosures that
research was done without consent on some patients at the VA hospital in
West Los Angeles. All research at that hospital was shut down to assure the
safety of all research subjects, and investigation of ongoing research at
numerous other VA hospitals is under way.
What does this mean for how research is carried out, and more importantly,
for the patients and other subjects who agree to take part in research? Are
these examples a sign that a few bureaucratic requirements have been
neglected, or do they mean subjects are at risk of serious harm? Or does the
truth lie somewhere in between?
A broken system?
Protection of research subjects relies on local review boards,
called IRBs (institutional review boards), making sure
federal rules to protect human subjects are followed. They
review and approve the ethics of all research studies before
subjects are recruited, monitor ongoing research, and
collect and report all information about harm to subjects in
research.
In 1996, Congress asked the federal Government Accounting Office to study
the research subjects protection system. Its report painted a picture of
a system in crisis -- too much work for IRBs, too few resources to do their
work, and too many research studies, forcing IRBs to take it on
faith that researchers comply with requirements. And while
government oversight officials have the authority to visit institutions to
check on research protections, limited funds make site visits rare except
when serious violations are reported.
Why worry about protections?
So are all subjects at risk? There is no reason to think that all, or even
some, researchers are motivated to mistreat research subjects. But both
researchers and subjects may have motivations that work against adequate
protection. Researchers are motivated to recruit subjects, and
subjects are often motivated by the hope of improved health. Add the fact
that both researchers and subjects are sometimes paid for research, and it
is clear that more objective oversight is necessary to look after the rights
and interests of subjects.
As current events attest, even when protections exist, they don't do
their job unless they're adequately applied. But even with conscientious
oversight, some research falls through the cracks. There are no
special protections for research on those with limited abilities to make
decisions, or on individuals who live in institutions -- some mentally ill
subjects may fall into both categories. These gaps are the focus of current
policy attention, but research on such groups continues in the meantime.
The bottom line
Protection is needed, not because of the
information yielded by research or the finances at stake,
though both are substantial -- Duke's suspended research is leading-edge
science reportedly worth $175 million a year. What really matters is
protection of the trust that is fundamental to the existence of the
research enterprise. Research subjects can't be expected to scrutinize the
records of research institutions to make sure regulations are followed, and
they shouldn't have to. Subjects must be able to rely on
their trust in investigators, in institutions, and in the policies
that exist to protect them.
This is not idle trust but a willingness to put their health and their lives into someone else's hands. It is a trust that must be maintained throughout the
research system, because without it individuals won't participate, and
society will lose confidence in the value of research altogether. There is
much to be gained from research, but even great benefits
cannot come at the cost of adequate respect for individuals. Real people,
with real lives, make research possible. They deserve real
protection.
|
The research scandal of the week is that Duke University Medical Center had
its license to carry out clinical research revoked and then reinstated by
the federal government. Is the research subject protection system broken?
What do recent scandals mean for how research is carried out? Are the
shortcomings just a few bureaucratic requirements that have been neglected,
or are subjects at risk of serious harm?
Post your opinion here.
|
Visit the "Ethics Matters" Archive where you'll find other columns from Jeffrey Kahn on a wide range of bioethics topics.
"Ethics Matters" is a biweekly feature from the Center for Bioethics and CNN Interactive.
LATEST HEALTH STORIES:
China SARS numbers pass 5,000
Report: Form of HIV in humans by 1940
Fewer infections for back-sleeping babies
Pneumonia vaccine may help heart, too
|